comparemela.com

Latest Breaking News On - Alliance for aging research - Page 8 : comparemela.com

Investigation Questions Drug s Approval for Agitation in AD

FDA approved Rexulti to be the first antipsychotic for treating agitation in elderly patients with dementia

In trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making Rexulti the first antipsychotic for treating agitation in elderly patients with dementia.

FDA Fast-Tracks Antipsychotic Drug for Dementia Agitation

FDA Fast-Tracks Antipsychotic Drug for Dementia Agitation
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Alarm as FDA fast-tracks first antipsychotic drug for agitation in dementia

Alarm as FDA fast-tracks first antipsychotic drug for agitation in dementia
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

FDA Rushes Approval of First Dementia Agitation Drug

FDA Rushes Approval of First Dementia Agitation Drug
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.